Aubrey de Grey
Aubrey David Nicholas Jasper de Grey (born 20 April 1963) is an English author and biomedical gerontologist. He is the Chief Science Officer of the SENS Research Foundation and VP of New Technology Discovery at AgeX Therapeutics, Inc. De Grey is a proponent of the idea that medical technology may enable human beings to significantly extend their healthy lifespans by preventing the aging process. He is also known for his view that the first human beings who will live to 1,000 years old have already been born. De Grey's research focuses on the identification and repair of the damage that accumulates in the body over time, leading to aging and age-related diseases.
Early Life and Education[edit]
Aubrey de Grey was born in London, England. He was educated at Harrow School before moving on to study at the University of Cambridge, where he graduated with a degree in Computer Science. After his initial studies, de Grey's interest in the biology of aging developed, leading him to pursue a Ph.D. in biology at Cambridge. His doctoral thesis focused on the subject of senescence, the gradual deterioration of function characteristic of aging.
Career[edit]
De Grey's career has been dedicated to the field of biogerontology. He has proposed a detailed plan for reversing aging, termed Strategies for Engineered Negligible Senescence (SENS), which is aimed at repairing the damage that accumulates in the body over time. De Grey has authored several books on the subject, including "Ending Aging: The Rejuvenation Breakthroughs That Could Reverse Human Aging in Our Lifetime," co-authored with Michael Rae.
In addition to his role at the SENS Research Foundation, de Grey has been involved in various other projects and organizations related to aging and longevity. He has been a significant figure in the formation of the Methuselah Foundation and has been involved in the creation of the Mprize, a competition designed to encourage research into extending the healthy lifespan of mice, which is seen as a step towards extending human healthspan.
Controversies[edit]
De Grey's views on aging and his predictions for the future of human longevity have been met with skepticism by some members of the scientific community. Critics argue that his predictions are overly optimistic and that the science behind SENS is not sufficiently proven. Despite this, de Grey's work has contributed to increasing public and scientific interest in the possibility of treating aging as a disease.
Personal Life[edit]
De Grey is known for his distinctive appearance, often seen with a long beard. He has been open about his unconventional lifestyle and views on personal relationships, which have also attracted media attention.
Legacy and Impact[edit]
Aubrey de Grey's work has had a significant impact on the field of biogerontology and the broader conversation about aging and longevity. His advocacy for the scientific pursuit of significant lifespan extension has inspired a new generation of researchers and brought attention to the potential for future breakthroughs in the treatment of aging.
See Also[edit]
-
Aubrey de Grey - How We Will Beat Aging
-
Aubrey de Grey
-
Aubrey de Grey at the St. Gallen Symposium 2014
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
